SentiSense
Ctrl+K
Quick tip: Press
to search stocks
P
PFE
Pfizer Inc.
$26.58
-0.28 (-1.04%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
2764
tracked filers
Total Institutional Value
$43.3B
2764 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (1)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
STATE STREET CORP | Index Fund | 299.1M | $7.6B | -- | +0.9% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 112.8M | $2.9B | -- | +0.8% |
NORGES BANK | Sovereign Wealth | 88.4M | $2.6B | -- | -5.7% |
WELLINGTON MANAGEMENT GROUP LLP | Other | 56.5M | $1.4B | -- | -22.3% |
Fisher Asset Management, LLC | Other | 49.3M | $1.3B | -- | +1.9% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
PFE
Market Cap
$152.73B
IPO Date
Jun 22, 1951
CEO
Albert Bourla
Employees
75,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Read MoreSimilar Stocks
MRNA
Moderna Inc.
$52.56
-1.55%
MRK
Merck & Co., Inc.
$115.61
-0.26%
JNJ
Johnson & Johnson
$241.52
-0.21%
VTRS
Viatris Inc.
$13.51
-2.10%
ZTS
Zoetis Inc.
$115.62
+0.14%